Skip to main content

Novo Nordisk cuts sales forecast

Danish insulin manufacturer Novo Nordisk has posted 15 percent growth in operating profit in local currencies in the first quarter of this year but cut its sales outlook for 2014.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.